Accepting applications until August 1
Accepting applications until August 1
Hongmei Zeng, Rongshou Zheng, Kexin Sun et al. J Natl Cancer Cent. 2024 Jun 22;4(3):203-213
A milestone goal of the Healthy China Program (2019-2030) is to achieve 5-year cancer survival at 43.3% for all cancers combined by 2022. To assess the progress towards this target, we analyzed the updated survival for all cancers... Read More
Habtamu Mellie Bizuayehu, Abel F Dadi, Kedir Y Ahmed Cancer 2024 Nov 1;130(21):3708-3723
Men exhibit higher prevalence of modifiable risk factors, such as smoking and alcohol consumption, leading to greater cancer incidence and lower survival rates. The authors analyzed 30 cancer types among men in 2022, with projecti... Read More
Habtamu Mellie Bizuayehu, PhD, MPH; Kedir Y. Ahmed, PhD; Getiye Dejenu Kibret, P JAMA
Cancer prevention and care efforts have been challenged by the COVID-19 pandemicand armed conflicts, resulting in a decline in the global Human Development Index (HDI), particularly in low- and middle-income countries. This popula... Read More
C. Santucci1, S. Mignozzi1, F. Levi, M. et al. Annals of Oncology Volume 36 - Issue 4 – 2025
We predicted the number of cancer deaths and rates for 2025 in the European Union (EU), its five most populous countries, and the UK, focusing on breast cancer. We estimated 1,280 000 cancer deaths in the EU in 2025, corresponding... Read More
Rebecca L. Siegel, Tyler B. Kratzer, Nikita Sandeep Wagle, et al. CA Cancer J Clin. 2026;e 70043
In 2026, approximately 2,114,850 new cancer cases and 626,140 cancer deaths are projected to occur in the United States. The cancer mortality rate continued to decline through 2023, averting 4.8 million deaths since 1991, largely... Read More